Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page
Price
Target price
€29.40

€29.40

-0.680%
-0.2
-0.680%
€30.00

€30.00

 
Latest predictions
€27.00
11.09.20
-
10.09.20
€20.00
14.03.20
buy
€51.00
15.09.19
buy
€30.00
06.09.19
buy
€31.57
13.06.19
buy
Your prediction

Aimmune Therapeutics Inc Stock

The price for the Aimmune Therapeutics Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.680%).
With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of €30.00 there is a slightly positive potential of 2.041% for Aimmune Therapeutics Inc compared to the current price of €29.40.

Pros and Cons of Aimmune Therapeutics Inc in the next few years

Pros
?
Market Position
?
Growth compared to competition
?
Worthwhile Investment for the next years
Cons
?
Conscious of the environment
?
Brand
?
Non-cyclic/Cyclic
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Sell Aimmune Therapeutics Inc

Published 23.12.19
Prediction Sell
Perf. (%) 26.087%
Target price
Change

Sell beendet

Sell Aimmune Therapeutics Inc

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Aimmune Therapeutics Inc Stock

New thread Forum

News

Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science


Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it has entered